(Q35954213)

11 August 2017

1 reference

title

Sensitization of chemotherapy by anti-HER. (English)

1 reference

11 August 2017

4

Shinji Ohno

1 reference

11 August 2017

Akemi Kataoka

1

1 reference

11 August 2017

Mayumi Ishida

series ordinal

2

1 reference

11 August 2017

Shigeru Murakami

series ordinal

3

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

11

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

105-115

1 reference

Trastuzumab/chemotherapy combinations in metastatic breast cancer

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02968288

21 January 2018

Identifiers

DOI

10.1007/BF02968288

1 reference

release_oz5rfysy45b6rl2zbpnnicbfp4

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oz5rfysy45b6rl2zbpnnicbfp4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference